440 - Improvement of pharmacokinetics and myeloid effector cell engagement in vivo by Fc-engineering of IgA antibody against the epidermal growth factor receptor.
Saved in:
| Title: | 440 - Improvement of pharmacokinetics and myeloid effector cell engagement in vivo by Fc-engineering of IgA antibody against the epidermal growth factor receptor. |
|---|---|
| Authors: | Rösner, T., Kretschmer, A., Lohse, S., Meyer, S., Jansen, J.H.M., Möginger, U., Sondermann, P., Kolarich, D., Leusen, J.H.W., Valerius, T. |
| Source: | European Journal of Cancer. Dec2016 Supplement 1, Vol. 69, pS144-S144. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09598049 |
|---|---|
| DOI: | 10.1016/S0959-8049(16)33027-1 |
